Avedro Inc Receivables Turnover Ratio (AVDR), from the third quarter 2019 to the third quarter 2018 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Avedro Inc  (NASDAQ: AVDR)
 

Avedro Inc Accounts Receivables Turnover Ratio from the third quarter 2019 to the third quarter 2018

Quarterly Results, Trends, Rankings, Statistics


Avedro Inc's ability to collect accounts receivable sequentially worsen to 3.79, indicating more challenging environment then in the second quarter 2019, but still, it is a far cry from any concerns. Avedro Inc's Accounts Receivable average collection period in the Sep 30 2019 quarter, has increased to 96 days, from 76 days, in the Jun 30 2019 quarter.

If we take a look into Healthcare sector Avedro Inc achieved the highest receivable turnover ratio. While receivables turnover ratio remained unchanged relative to the previous period at no. .

What is Receivable Turnover Ratio?
What is Avedro Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AVDR Receivables Turnover Ratio (Sep 30 2019)
III. Quarter		 (Jun 30 2019)
II. Quarter		 (Mar 31 2019)
I. Quarter		 (Sep 30 2018)
III. Quarter		 (Jun 30 2018)
II. Quarter
Y / Y Receivable Change - - - - -
Y / Y Revenue Change 75.47 % 99.63 % - - -
Receivable Turnover Ratio (TTM) 3.79 4.79 6.94 14.7 -
AVDR's Total Ranking # # # # #
Accounts Receivable average collection period days 96 76 53 25 -
Seq. Receivable Change 6.25 % 5.74 % 107.12 % - -
Seq. Revenue Change 7.36 % 17.28 % 9.42 % 27.37 % 22.14 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Receivable Turnover Ratio Statistics
High Average Low
0 0 0
 





AVDR Company Profile • Back to AVDR Efficiency Comparisons • Compare AVDR Receivables Turnover Ratio to its Competitors

Financial Statements
Avedro Inc's Accounts Receivable $ 12 Millions Visit AVDR's Balance sheet
Avedro Inc's Sales TTM $ 38 Millions Visit AVDR's Income Statement
Sources of AVDR's Revenues Visit AVDR's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
AVDR's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
AVDR's Growth Rates AVDR's Roa AVDR's Inventory Turnover Ratio AVDR's Dividend Comparisons
AVDR's Profitability Ratios AVDR's Roi AVDR's Asset Turnover Ratio AVDR's Dividend Growth
AVDR's Valuation Ratios AVDR's Roe AVDR's Financial Strength Ratios AVDR's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2019, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2019 Receivable at quarter ending Sep 30 2019
Earth Science Tech Inc   8.47 $ 0.770  Millions$ 0.091  Millions
American Bio Medica Corporation  8.47 $ 3.660  Millions$ 0.432  Millions
Intellia Therapeutics Inc   8.46 $ 40.047  Millions$ 4.731  Millions
Genmark Diagnostics Inc   8.46 $ 80.203  Millions$ 9.477  Millions
Quotient Limited  8.41 $ 31.019  Millions$ 3.689  Millions
Inspire Medical Systems inc   8.40 $ 71.703  Millions$ 8.538  Millions
Atricure Inc   8.34 $ 222.379  Millions$ 26.652  Millions
Avid Bioservices Inc   8.34 $ 64.403  Millions$ 7.726  Millions
Heska Corporation  8.32 $ 122.958  Millions$ 14.787  Millions
Vanda Pharmaceuticals Inc   8.29 $ 219.299  Millions$ 26.460  Millions
Adamas Pharmaceuticals Inc  8.27 $ 51.604  Millions$ 6.239  Millions
Vertex Pharmaceuticals Inc  8.24 $ 3,619.662  Millions$ 439.050  Millions
Portola Pharmaceuticals inc   8.24 $ 102.690  Millions$ 12.457  Millions
Quidelortho Corp  8.24 $ 515.300  Millions$ 62.550  Millions
Alpha Pro Tech Ltd   8.22 $ 46.715  Millions$ 5.684  Millions
Amedisys Inc  8.22 $ 1,889.390  Millions$ 229.947  Millions
Inotiv Inc   8.21 $ 43.616  Millions$ 5.313  Millions
Tandem Diabetes Care Inc   8.15 $ 330.106  Millions$ 40.496  Millions
Premier Biomedical Inc  8.12 $ 0.022  Millions$ 0.003  Millions
Irhythm Holdings Inc   8.08 $ 198.373  Millions$ 24.564  Millions
Cutera Inc   8.07 $ 175.386  Millions$ 21.729  Millions
Atrion Corporation  8.04 $ 155.526  Millions$ 19.348  Millions
Beone Medicines Ltd   8.04 $ 429.990  Millions$ 53.513  Millions
Viemed Healthcare Inc   8.02 $ 23.525  Millions$ 2.932  Millions
Encision Inc   8.01 $ 8.055  Millions$ 1.006  Millions
Genomic Health Inc  8.00 $ 441.873  Millions$ 55.240  Millions
Vaso Corporation  7.98 $ 71.031  Millions$ 8.906  Millions
Aptinyx Inc   7.96 $ 3.790  Millions$ 0.476  Millions
Invacare Holdings Corporation  7.96 $ 939.627  Millions$ 118.082  Millions
Neurocrine Biosciences Inc   7.95 $ 675.569  Millions$ 85.011  Millions

Date modified: 2026-09-08T15:09:42+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.